NCT03863353

Brief Summary

Legitimate prescription opioid use during adolescence has been associated with later prescription opioid misuse and substance use disorder symptoms during adulthood. Thus, primary prevention interventions for older adolescents and young adults (15-24 yrs) at the time of prescribing are imperative. The goal of our research is to improve opioid analgesic safety and efficacy by optimizing opioid risk recognition and informed decision-making among 15-24 year olds who are prescribed these agents for home use. Young adults and older adolescents who manage their own prescription pain medicines need to recognize opioid-related risks and make decisions that will both reduce these risks yet ensure effective pain relief. The proposed research will evaluate new strategies to help subjects learn about opioid risks and make safe and effective analgesic decisions. 355 subjects who are undergoing an elective surgical procedure will be recruited. Subjects will be randomized to receive the new educational routine information. Subjects' knowledge and perceptions will be evaluated at baseline and at critical times after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
503

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 5, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
4 months until next milestone

Results Posted

Study results publicly available

April 6, 2022

Completed
Last Updated

April 6, 2022

Status Verified

March 1, 2022

Enrollment Period

2.1 years

First QC Date

February 21, 2019

Results QC Date

December 22, 2021

Last Update Submit

March 13, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Opioid Risk Perception

    Perceived riskiness of opioid misuse (0-40 where 40 indicates highest risk perception)

    Baseline, day 14, 3 months post intervention

Secondary Outcomes (1)

  • Opioid Misuse Intention Decisions

    3 months post intervention

Study Arms (2)

Education Intervention

EXPERIMENTAL

This group will receive the scenario-tailored STOMP educational feedback

Behavioral: Educational Intervention

Control

NO INTERVENTION

This group will receive only standard of care information.

Interventions

This intervention provides scenario-tailored opioid risk message feedback immediately following interactive analgesic decision-making exercises.

Also known as: STOMP Intervention
Education Intervention

Eligibility Criteria

Age15 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Undergoing an elective surgical procedure for which it is expected they will receive a prescription pain medicine for management of pain during recovery at home.

You may not qualify if:

  • Undergoing non-elective procedure
  • Cognitive impairment precluding self-reporting of pain
  • Hematologic/oncologic condition
  • Liver of kidney conditions precluding usual analgesic prescription patters (opioid plus a non-opioid)
  • Use of opioids for prolonged pain pre-operatively (\<2 weeks)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Michigan, C.S. Mott Children's Hospital

Ann Arbor, Michigan, 48109, United States

Location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Pain, PostoperativeMedication AdherenceBehaviorRisk Reduction Behavior

Interventions

Early Intervention, Educational

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health Services

Results Point of Contact

Title
Dr. Terri Voepel-Lewis
Organization
University of Michigan

Study Officials

  • Terri Voepel-Lewis, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Group assignment will be coded for subjects and data collectors. Subjects will be blinded to whether the information they receive is the Intervention vs. Control. Group assignment will coded on data entry and unblinded after analyses.
Purpose
PREVENTION
Intervention Model
FACTORIAL
Model Details: randomized, controlled, factorial design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicipal Investigator

Study Record Dates

First Submitted

February 21, 2019

First Posted

March 5, 2019

Study Start

November 1, 2019

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

April 6, 2022

Results First Posted

April 6, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations